// App-Quantinova.ai

AB0398 : DISPOSITIONAL OPTIMISM AND DEPRESSION SEVERITY IN EARLY ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND DMARD-COMBINATION THERAPY IN THE IMPROVED STUDY

Researchers

Presenter

  • L. Heimans

Principal Investigators

  • K. Wevers-de Boer

  • K. Visser

  • J. Van Groenendael

  • L. Lard

  • P. de Sonnaville

  • R. van der Mast

  • E. Giltay

  • T. Huizinga

  • C. Allaart

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Depression

  • Inflammatory Arthritis

Biomarkers

  • Sperm Acrosome Associated 9

Drug/Treatment

  • Hydroxychloroquine

  • sulphasalazine

  • Methotrexate

  • Adalimumab

  • Prednisone

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim